Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04791371

Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
All
Age
30 Years – 55 Years
Healthy volunteers
Accepted

Summary

The goal of this two-site grant proposal is to determine the role of the decreased insulin-mediated muscle perfusion found in type 2 diabetes in contributing to the development of cardiac and skeletal muscle dysfunction and subsequent functional exercise impairment. In addition, it is also our goal to determine whether exercise training attenuates insulin resistance and restores insulin-mediated perfusion to the heart and to skeletal muscle, leading to improved cardiac function and exercise performance.

Detailed description

It is our goal to determine whether exercise training attenuates insulin resistance and restores insulin-mediated perfusion to the heart and to skeletal muscle, leading to improved cardiac function and exercise performance. Data from our two research teams suggest that the cardiac and skeletal muscle microvascular dysfunction present in people with type 2 diabetes contributes to limitations in cardiac and skeletal muscle function associated with impaired functional exercise capacity (a major predictor of CV and all-cause mortality). Insulin action is a potent predictor of the functional exercise capacity impairment in type 2 diabetes. The exact relationship between insulin action, cardiac and muscle dysfunction, cardiac and skeletal muscle perfusion and decreased functional exercise capacity in type 2 diabetes remains unclear.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCardiovascular exercise15 weeks of cardiovascular exercise 3x/week for 50 minutes/session

Timeline

Start date
2022-06-17
Primary completion
2027-01-15
Completion
2027-02-15
First posted
2021-03-10
Last updated
2026-03-23

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04791371. Inclusion in this directory is not an endorsement.